Anticorps Polyclonal de lapin anti-FBXO31

FBXO31 Polyclonal Antibody for WB, IHC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris

Applications

WB, IHC, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 27294-1-PBS

Synonymes

F box only protein 31, F box protein 31, F-box only protein 31, FBX14, FBX31

---

Galerie de données de validation

• 

  WB analysis of mouse brain using 27294-1-AP (same clone as 27294-1-PBS)

  mouse brain tissue were subjected to SDS PAGE followed by western blot with 27294-1-AP (FBXO31 Antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 27294-1-PBS in a different storage buffer formulation.

• 

  IHC staining of mouse uterus using 27294-1-AP (same clone as 27294-1-PBS)

  Immunohistochemical analysis of paraffin-embedded mouse uterus tissue slide using 27294-1-AP (FBXO31 antibody) at dilution of 1:1200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 27294-1-PBS in a different storage buffer formulation.

---

Informations sur le produit

27294-1-PBS cible FBXO31 dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain, souris

• Réactivité: Humain, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: FBXO31 Protéine recombinante Ag24867
• Nom complet: F-box protein 31
• Poids moléculaire observé: 49 kDa, 60-70 kDa
• Numéro d’acquisition GenBank: BC012748
• Symbole du gène: FBXO31
• Identification du gène (NCBI): 79791
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

FBXO31, also known as F-box protein 31, is a substrate recognition protein of the SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex. It plays a crucial role in mediating the ubiquitination and subsequent degradation of target proteins through the ubiquitin-proteasome system. In pancreatic cancer, FBXO31 is upregulated and promotes cancer progression by targeting proteins like SIRT2 for degradation (PMID: 38216561). In endometrial cancer, FBXO31 acts as a tumor suppressor by regulating the ubiquitination of OGT (O-GlcNAc transferase), which affects cellular O-GlcNAcylation levels (PMID: 39894887). FBXO31 Is a reader of C-terminal amides, which ubiquitylates CTAPs for subsequent proteasomal degradation. A dominant de novo D334N mutation in FBXO31 alters FBXO31 substrate recognition and CTAP clearance, causing some important proteins to be degraded and clinical intellectual impairment or diplegic spastic cerebral (PMID: 39880951).

{{ptg:RelatedPrimaryAntibodies}}